MET and colorectal carcinoma: Moreover, although MET/HGF blockade did not prevent AI-induced hypoxia, it fully suppressed metastatic spreading of both HCT-116 and HT-29 CRC cells to either the liver (Figure 9A) or the lungs (Figure 9B).